The Clorox Company (NYSE:CLX) Shares Bought by WCM Investment Management LLC

WCM Investment Management LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 356.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,466 shares of the company's stock after purchasing an additional 5,829 shares during the quarter. WCM Investment Management LLC's holdings in Clorox were worth $1,220,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Innealta Capital LLC purchased a new position in Clorox during the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC boosted its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after buying an additional 130 shares during the period. First Foundation Advisors purchased a new position in shares of Clorox in the 1st quarter valued at about $31,000. Family Firm Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at about $31,000. Finally, Quarry LP boosted its stake in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after buying an additional 114 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and lifted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and raised their target price for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. BNP Paribas raised Clorox to a "strong sell" rating in a research report on Friday, September 6th. DA Davidson raised their target price on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research report on Monday, November 4th. Finally, Citigroup lifted their price target on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Five research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Clorox currently has an average rating of "Hold" and a consensus target price of $155.00.

Clorox Stock Performance

Shares of CLX stock traded up $0.67 during midday trading on Wednesday, hitting $165.46. The company had a trading volume of 299,793 shares, compared to its average volume of 1,241,330. The company's 50 day simple moving average is $162.35 and its 200 day simple moving average is $147.08. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09. The stock has a market cap of $20.48 billion, a price-to-earnings ratio of 57.70, a PEG ratio of 3.04 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 earnings per share. The company's revenue for the quarter was up 27.0% compared to the same quarter last year. Research analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 2.95%. Clorox's payout ratio is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.